WallStreetZenWallStreetZen

NYSEMKT: ARMP
Armata Pharmaceuticals Inc Stock Ownership - Who owns Armata Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Armata Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Deborah BirxChief Executive Officer2026-03-144,919$10.54
$51.85kSell
Pierre KymeChief Business Officer2026-03-141,030$10.54
$10.86kSell
Deborah BirxChief Executive Officer2025-07-1013,637$2.27
$30.96kSell

1 of 1

ARMP insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ARMP insiders and whales buy or sell their stock.

ARMP Shareholders

What type of owners hold Armata Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Innoviva Inc68.45%25,076,769$323.99MInsider
Randal J. Kirk60.52%22,169,127$286.43MInsider
Biogen Inc38.05%13,939,158$180.09MInsider
Elan Corp PLC31.74%11,626,282$150.21MInsider
Austin W. Greenhouse David M. Marxe6.43%2,355,475$30.43MInsider
Delta Dental Of Wisconsin Inc5.75%2,107,675$27.23MInsider
Louis P. Lacasse3.96%1,450,185$18.74MInsider
Delta Dental Plan Of Michigan Inc3.46%1,265,802$16.35MInsider
Jeremy Curnock Cook1.12%411,435$5.32MInsider
Michael S. Perry1.12%411,335$5.31MInsider

1 of 3

ARMP vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ARMP1.50%98.50%Net SellingNet Selling
NMRA27.82%72.18%Net BuyingNet Selling
IPSC14.31%23.60%Net SellingNet Selling
VNDA50.12%49.88%Net SellingNet Selling
NAGE18.62%81.38%Net BuyingNet Buying
View Top Biotech Stocks

Armata Pharmaceuticals Stock Ownership FAQ

Who owns Armata Pharmaceuticals?

Armata Pharmaceuticals (NYSEMKT: ARMP) is owned by 3.41% institutional shareholders, 223.98% Armata Pharmaceuticals insiders, and 0.00% retail investors. Innoviva Inc is the largest individual Armata Pharmaceuticals shareholder, owning 25.08M shares representing 68.45% of the company. Innoviva Inc's Armata Pharmaceuticals shares are currently valued at $275.84M.

If you're new to stock investing, here's how to buy Armata Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.